Skip to main content
SpringerLink
Log in

Little evidence that supports a causal link between most vaccines and Guillain-Barré syndrome

  • Drug Reactions and Interaction
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Haber P, Sejvar J, Mikaeloff Y, et al. Vaccines and Guillain-Barré syndrome. Drug Saf 2009; 32(4): 309–23

    Article  PubMed  CAS  Google Scholar 

  2. Hughes RAC, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997; 176Suppl. 2: S92–8

    Article  PubMed  Google Scholar 

  3. Ellis O. Swine flu vaccine is a “thousandfold” safer than the infection, say experts. BMJ 2009. Epub Sep 16

  4. Institute of Medicine (IOM). Adverse events associated with childhood vaccines: evidence bearing on causality. Washington, DC: National Academy Press, 1994

    Google Scholar 

  5. Langmuir AD, Bregman DJ, Kurland LT, et al. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccine. Am J Epidemiol 1984; 119(6): 842–79

    Google Scholar 

  6. Institute of Medicine (IOM). Immunization safety review: influenza vaccines and neurological complications. Washington, DC: National Academies Press, 2003

    Google Scholar 

  7. Hughes RA, Charlton J, Latinovic R, et al. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006 Jun 26; 166(12): 1301–4

    Article  PubMed  Google Scholar 

  8. Haber P, DeStefano F, Angulo FJ, et al. Guillain-Barré syndrome following influenza vaccination. JAMA 2004 Nov 24; 292(20): 2478–81

    Article  PubMed  CAS  Google Scholar 

  9. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food: 10 states, 2007. MMWR Morb Mortal Wkly Rep 2008 Apr; 57(14): 366–70

    Google Scholar 

  10. Siddiqui A, Usmani RI, Anwer S, et al. Guillain-Barré syndrome occurring after rabies vaccination. J Pak Med Assoc 2005 Feb; 55(2): 87–8

    PubMed  Google Scholar 

  11. Salisbury DM. Association between oral poliovaccine and Guillain-Barré syndrome? Lancet 1998 Jan 10; 351(9096): 79–80

    Article  PubMed  CAS  Google Scholar 

  12. Tuttle J, Chen RT, Rantala H, et al. The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health 1997 Dec; 87(12): 2045–8

    Article  PubMed  CAS  Google Scholar 

  13. Pollard JD, Selby G. Relapsing neuropathy due to tetanus toxoid: report of a case. J Neurol Sci 1978; 37(1–2): 113–25

    Article  PubMed  CAS  Google Scholar 

  14. da Silveira CM, Salisbury DM, de Quadros CA. Measles vaccination and Guillain-Barré syndrome. Lancet 1997 Jan 4; 349(9044): 14–6

    Article  PubMed  Google Scholar 

  15. Patja A, Davidkin I, Kurki T, et al. Serious adverse events following measles-mumps-rubella vaccination during a 14-year prospective follow-up. Pediatr Infect Dis J 2000; 19(12): 1127–34

    Article  PubMed  CAS  Google Scholar 

  16. Patja A, Paunio M, Kinnunen E, et al. Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination. J Pediatr 2001; 138(2): 250–4

    Article  PubMed  CAS  Google Scholar 

  17. Centers for Disease Control and Prevention (CDC). Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine: United States, June–July 2005. MMWR Morb Mortal Wkly Rep 2005; 54(40): 1023–5

    Google Scholar 

  18. Centers for Disease Control and Prevention (CDC). Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine: United States, June 2005–September 2006. MMWR Morb Mortal Wkly Rep 2006; 55(41): 1120–4

    Google Scholar 

  19. De Wals P, Deceuninck G, Boucher RM, et al. Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada. Clin Infect Dis 2008 Apr; 46(8): e75–7

    Article  PubMed  Google Scholar 

  20. Geleijns K, Laman JD, van Rijs W, et al. Fas polymorphisms are associated the presence of anti-ganglioside antibodies in Guillain-Barré syndrome. J Neuroimmunol 2005 Apr; 161(1–2): 1893–9

    Google Scholar 

  21. Nachamkin I, Shadomy SV, Moran AP, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis 2008 Jul; 198(2): 226–32

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Little evidence that supports a causal link between most vaccines and Guillain-Barré syndrome. Drugs Ther. Perspect 25, 21–23 (2009). https://doi.org/10.2165/0042310-200925110-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0042310-200925110-00006

Search

Navigation